ITMI20042353A1 - Peptidi per la veicolazione di farmaci - Google Patents

Peptidi per la veicolazione di farmaci

Info

Publication number
ITMI20042353A1
ITMI20042353A1 IT002353A ITMI20042353A ITMI20042353A1 IT MI20042353 A1 ITMI20042353 A1 IT MI20042353A1 IT 002353 A IT002353 A IT 002353A IT MI20042353 A ITMI20042353 A IT MI20042353A IT MI20042353 A1 ITMI20042353 A1 IT MI20042353A1
Authority
IT
Italy
Prior art keywords
peptides
drug vehicles
drug
vehicles
Prior art date
Application number
IT002353A
Other languages
English (en)
Inventor
Luca Costantino
Flavio Forni
Maria Angela Vandelli
Original Assignee
Uni Degli Studi Di Modena E Re
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Di Modena E Re filed Critical Uni Degli Studi Di Modena E Re
Priority to IT002353A priority Critical patent/ITMI20042353A1/it
Publication of ITMI20042353A1 publication Critical patent/ITMI20042353A1/it
Priority to EP05817909A priority patent/EP1819723A2/en
Priority to PCT/EP2005/012554 priority patent/WO2006061101A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IT002353A 2004-12-10 2004-12-10 Peptidi per la veicolazione di farmaci ITMI20042353A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT002353A ITMI20042353A1 (it) 2004-12-10 2004-12-10 Peptidi per la veicolazione di farmaci
EP05817909A EP1819723A2 (en) 2004-12-10 2005-11-24 Drug delivery peptides for crossing blood-brain barrier
PCT/EP2005/012554 WO2006061101A2 (en) 2004-12-10 2005-11-24 Drug delivery peptides for crossing blood-brain barrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002353A ITMI20042353A1 (it) 2004-12-10 2004-12-10 Peptidi per la veicolazione di farmaci

Publications (1)

Publication Number Publication Date
ITMI20042353A1 true ITMI20042353A1 (it) 2005-03-10

Family

ID=36578268

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002353A ITMI20042353A1 (it) 2004-12-10 2004-12-10 Peptidi per la veicolazione di farmaci

Country Status (3)

Country Link
EP (1) EP1819723A2 (it)
IT (1) ITMI20042353A1 (it)
WO (1) WO2006061101A2 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010027108A1 (ja) * 2008-09-08 2010-03-11 国立大学法人東京工業大学 蛍光性糖誘導体化合物及びそれを用いるセンサー
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
US8747890B2 (en) 2009-11-19 2014-06-10 Signpath Pharma Inc. Intravenous infusion of curcumin and a calcium channel blocker
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
US10532045B2 (en) 2013-12-18 2020-01-14 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US8753674B2 (en) 2011-06-03 2014-06-17 Signpath Pharma Inc. Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
CA2882978A1 (en) 2012-08-31 2014-03-06 Signpath Pharma Inc. Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
AU2017257496B2 (en) 2016-04-27 2020-05-07 Signpath Pharma, Inc. Prevention of drug-induced atrio-ventricular block

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121982B4 (de) * 2001-05-05 2008-01-24 Lts Lohmann Therapie-Systeme Ag Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO2006061101A3 (en) 2006-09-14
EP1819723A2 (en) 2007-08-22
WO2006061101A2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
CY2025003I1 (el) Λιποσωματα για τη χορηγηση φαρμακων
DE602005015424D1 (de) Fahrzeugbetriebsunterstützungssystem
DE502004004673D1 (de) Fahrzeugsystem
DE602004020862D1 (de) Airbagsystem
DK1891962T3 (da) Glutathion-baseret afgivelsessystem
DE602004004745D1 (de) Wagensystem
DK1957073T3 (da) Lægemiddel
ITUD20050171A1 (it) Proiettore di veicolo
ITMO20050343A1 (it) Supporto per medicazione
ITMI20042353A1 (it) Peptidi per la veicolazione di farmaci
EP1804397A4 (en) AMPLIFIER
DE602005000630D1 (de) Airbagsystem
DK1817475T3 (da) Hybridt stigrørsystem
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE602005001938D1 (de) Fahrzeug
FI20050753L (fi) Uudet peptidit
DE502005004949D1 (de) Rückhaltesystem
NO20045614D0 (no) Booster
DK1769359T3 (da) Publikationsdata-verifikationssystem
DE602005000950D1 (de) Fahrzeug
CY1127305T1 (el) Λιποσωματα για τη χορηγηση φαρμακων
ITUD20040067A1 (it) Impianto di frenatura combinato per veicoli
ITMO20040147A1 (it) Rampa per veicoli
DE602006010792D1 (de) Airbagsystem
ITTO20040319A1 (it) Montante per veicoli